“…Rebound hyperkalemia occurred in 42% of our 24 episodes of hospitalized patients with TPP, with a maximum serum K level of 6.6 mmol/L, and this phenomenon is well described in the literature. 4,6,[8][9][10]14,[23][24][25] Hypophosphatemia during paralysis in patients with TPP has been previously reported 8,16,24,26,27 and may contribute to the muscle weakness 28 along with hypokalemia. In our study, 12 (80%) of 15 episodes had decreased serum levels of P when first seen, and only 4 of the episodes (patients 7, 17, 23, and 24 in Table 1) received replacement therapy with neutra-phos.…”